If this is the case, we suggest that the decreased ERCC1 expression and impaired ERCC1 function induced by mutant EGFR signals may relate to tumorigenesis, as well as chemosensitivity, in NSCLC with EGFR activating mutations. Here, EGFR is linked to non-small cell lung carcinoma.